The choice of treatment should be individualised, considering the underlying cause, symptom severity, patient preference, and practical factors such as access to healthcare facilities for regular injections
This makes it good for injury modeling, recovery timing studies, and tissue resilience testing
Priority research needs include large-scale randomized controlled trials to establish efficacy and safety, dose-ranging studies to optimize treatment protocols, long-term safety studies particularly regarding cancer risk, and comparative effectiveness research with established therapies
Nevertheless, this does not mean that oral BPC-157 will be ineffective for joint pain or that BPC-157 injections wont show GI effects
There is a combination peptide that blends two of the most powerful healing agents into a single vial: BPC-157 and TB-500